✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic DementiaGeriatricsEdiblesBehavioral SymptomsFamily Medicine Why This MattersDementia patients are increasingly being given cannabis edibles by...
Alzheimer’s | Center for Medical Cannabis | Utah Department of Health and Human Services
✦ New CED Clinical Relevance #76Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic Alzheimer'SNeurodegenerationState PolicyClinical GuidelinesBehavioral Symptoms Why This MattersUtah's evidence-based guidelines represent one of the first...
Medicinal Cannabis Shows Efficacy for Alzheimer’s Palliative Care – Sechat
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic Alzheimer'S DiseasePalliative CareNeuroinflammationBehavioral SymptomsGeriatrics Why This MattersAlzheimer's disease affects nearly 7 million Americans with...
Cannabinoids for Autism: Clinical Evidence Reviewed
Clinical Takeaway CBD-based treatments, particularly cannabidiol-rich preparations, have shown preliminary benefits for certain autism-associated behaviors such as irritability, hyperactivity, and social communication challenges in some clinical trials. However, the current evidence base...
Rigorous CBD Trial for Autism Behavioral Symptoms Launches—But Results Are Not Yet In
There is a significant need for clinical research exploring alternative medications for the treatment of behavioral symptoms of ASD. Cannabidiol (CBD) is being studied for the management of irritability, aggression, and other problem behaviors associated with ASD.
Endocannabinoid System Research: Cannabis for Autism
Clinical Takeaway Across randomized clinical trials, cannabis derivatives and their analogs showed promising early signals for improving core and associated symptoms of autism spectrum disorder, including social communication and behavioral challenges. The...
Cannabinoid Clinical Trials: CBD Gel Safety in Fragile X
Clinical Takeaway Transdermal cannabidiol gel (ZYN002) has been studied in children and adolescents with Fragile X syndrome through an open-label extension trial focused on long-term safety and tolerability. Early interim data suggest...
Endocannabinoid System Research: Cannabis & Autism Review
Clinical Takeaway Cannabinoid-based treatments, including CBD-rich preparations, have shown preliminary benefits for certain autism-related symptoms such as irritability, hyperactivity, and sleep difficulties in clinical trial data. The evidence base remains limited in...
Cannabinoids for Autism: Clinical Evidence & ASD Research
Clinical Takeaway Several randomized clinical trials have examined cannabis derivatives, including CBD-rich preparations, for core and associated symptoms of autism spectrum disorder, with findings suggesting potential benefits for behavioral challenges, anxiety, and...